y A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY (THE ALIGN STUDY) Heerspink, H., Kohan, D., Lafayette, R., Levin, A., Zhang, H., Glicklich, A., Camargo, M., King, A., Barratt, J. OXFORD UNIV PRESS. 2021: 194

View details for Web of Science ID 000713465600394